Gout Therapeutics Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL GOUT THERAPEUTICS INDUSTRY

2.1 Summary about Gout Therapeutics Industry

2.2 Gout Therapeutics Market Trends

2.2.1 Gout Therapeutics Production & Consumption Trends

2.2.2 Gout Therapeutics Demand Structure Trends

2.3 Gout Therapeutics Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 NSAIDs

4.2.2 Corticosteroids

4.2.3 Colchicine

4.2.4 Urate-Lowering Agents

4.2.5 Others

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Hospital Pharmacies

4.3.2 Retail Pharmacies

4.3.3 Online Pharmacies

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 NSAIDs

5.2.2 Corticosteroids

5.2.3 Colchicine

5.2.4 Urate-Lowering Agents

5.2.5 Others

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Hospital Pharmacies

5.3.2 Retail Pharmacies

5.3.3 Online Pharmacies

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 NSAIDs

6.2.2 Corticosteroids

6.2.3 Colchicine

6.2.4 Urate-Lowering Agents

6.2.5 Others

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Hospital Pharmacies

6.3.2 Retail Pharmacies

6.3.3 Online Pharmacies

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 NSAIDs

7.2.2 Corticosteroids

7.2.3 Colchicine

7.2.4 Urate-Lowering Agents

7.2.5 Others

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Hospital Pharmacies

7.3.2 Retail Pharmacies

7.3.3 Online Pharmacies

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 NSAIDs

8.2.2 Corticosteroids

8.2.3 Colchicine

8.2.4 Urate-Lowering Agents

8.2.5 Others

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Hospital Pharmacies

8.3.2 Retail Pharmacies

8.3.3 Online Pharmacies

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 NSAIDs

9.2.2 Corticosteroids

9.2.3 Colchicine

9.2.4 Urate-Lowering Agents

9.2.5 Others

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Hospital Pharmacies

9.3.2 Retail Pharmacies

9.3.3 Online Pharmacies

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 AstraZeneca

10.1.2 Takeda Pharmaceuticals

10.1.3 Horizon Pharma

10.1.4 Merck

10.1.5 Novartis

10.1.6 Sanofi

10.1.7 GlaxoSmithKline

10.1.8 Eli Lilly

10.1.9 Boehringer Ingelheim

10.1.10 Novo Nordisk

10.1.11 LG Life Sciences

10.1.12 Antares Pharma

10.1.13 Astellas Pharma

10.1.14 Eisai

10.1.15 JW Pharmaceutical

10.1.16 Teijin Pharma

10.1.17 Vertex Pharmaceuticals

10.1.18 Sandoz

10.1.19 Regeneron Pharmaceuticals

10.1.20 CymaBay Therapeutics

10.1.21 Ablynx

10.2 Gout Therapeutics Sales Date of Major Players (2017-2020e)

10.2.1 AstraZeneca

10.2.2 Takeda Pharmaceuticals

10.2.3 Horizon Pharma

10.2.4 Merck

10.2.5 Novartis

10.2.6 Sanofi

10.2.7 GlaxoSmithKline

10.2.8 Eli Lilly

10.2.9 Boehringer Ingelheim

10.2.10 Novo Nordisk

10.2.11 LG Life Sciences

10.2.12 Antares Pharma

10.2.13 Astellas Pharma

10.2.14 Eisai

10.2.15 JW Pharmaceutical

10.2.16 Teijin Pharma

10.2.17 Vertex Pharmaceuticals

10.2.18 Sandoz

10.2.19 Regeneron Pharmaceuticals

10.2.20 CymaBay Therapeutics

10.2.21 Ablynx

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

1.Table Gout Therapeutics Product Type Overview

2.Table Gout Therapeutics Product Type Market Share List

3.Table Gout Therapeutics Product Type of Major Players

4.Table Brief Introduction of AstraZeneca

5.Table Brief Introduction of Takeda Pharmaceuticals

6.Table Brief Introduction of Horizon Pharma

7.Table Brief Introduction of Merck

8.Table Brief Introduction of Novartis

9.Table Brief Introduction of Sanofi

10.Table Brief Introduction of GlaxoSmithKline

11.Table Brief Introduction of Eli Lilly

12.Table Brief Introduction of Boehringer Ingelheim

13.Table Brief Introduction of Novo Nordisk

14.Table Brief Introduction of LG Life Sciences

15.Table Brief Introduction of Antares Pharma

16.Table Brief Introduction of Astellas Pharma

17.Table Brief Introduction of Eisai

18.Table Brief Introduction of JW Pharmaceutical

19.Table Brief Introduction of Teijin Pharma

20.Table Brief Introduction of Vertex Pharmaceuticals

21.Table Brief Introduction of Sandoz

22.Table Brief Introduction of Regeneron Pharmaceuticals

23.Table Brief Introduction of CymaBay Therapeutics

24.Table Brief Introduction of Ablynx

25.Table Products & Services of AstraZeneca

26.Table Products & Services of Takeda Pharmaceuticals

27.Table Products & Services of Horizon Pharma

28.Table Products & Services of Merck

29.Table Products & Services of Novartis

30.Table Products & Services of Sanofi

31.Table Products & Services of GlaxoSmithKline

32.Table Products & Services of Eli Lilly

33.Table Products & Services of Boehringer Ingelheim

34.Table Products & Services of Novo Nordisk

35.Table Products & Services of LG Life Sciences

36.Table Products & Services of Antares Pharma

37.Table Products & Services of Astellas Pharma

38.Table Products & Services of Eisai

39.Table Products & Services of JW Pharmaceutical

40.Table Products & Services of Teijin Pharma

41.Table Products & Services of Vertex Pharmaceuticals

42.Table Products & Services of Sandoz

43.Table Products & Services of Regeneron Pharmaceuticals

44.Table Products & Services of CymaBay Therapeutics

45.Table Products & Services of Ablynx

46.Table Market Distribution of Major Players

47.Table Global Major Players Sales Revenue (Million USD) 2017-2020e

48.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

49.Table Global Gout Therapeutics Market Forecast (Million USD) by Region 2021f-2026f

50.Table Global Gout Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f

51.Table Global Gout Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f

52.Table Global Gout Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f